Thursday, September 24, 2015

CEO promises to lower controversial price of key drug

The 5,000-percent overnight price hike on a crucial infection treatment drug created outrage that Turing Pharmaceuticals initially dismissed

From: http://www.cbsnews.com/news/ceo-martin-shkreli-promises-to-lower-controversial-price-of-daraprim/

No comments:

Post a Comment